Strength
3.5 mg/1
Manufacturer
Apotex Corp.NDC
60505605004
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Last Updated
3/19/2025
Active Ingredients
BORTEZOMIBApproval Type
Generic (ANDA)
FDA Application
ANDA205533On Market Since
5/2/2022
Pharmacological Classes
Proteasome Inhibitor
Proteasome Inhibitors
Related Drugs
Same classification
BORTEZOMIB 3.5 MG VIAL
Generic
00409170001•Hospira Inc.
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
31722030331•Camber Pharmaceuticals Inc.
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
43598042660•Dr. Reddy's Laboratories Inc.
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
50742048401•Ingenus Pharmaceuticals LLC
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
55150033701•Eugia US LLC
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
63323082110•Fresenius Kabi USA, LLC
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
68001053436•BluePoint Laboratories
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
68001054036•BluePoint Laboratories
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
68001054136•BluePoint Laboratories
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
70710141101•Zydus Pharmaceuticals (USA) Inc.
$43.3460
per EA